Japan Metabotropic Glutamate Receptor 5 Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Metabotropic Glutamate Receptor 5 market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Metabotropic Glutamate Receptor 5 market. Detailed analysis of key players, along with key growth strategies adopted by Metabotropic Glutamate Receptor 5 industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Bristol-Myers Squibb Company

    • Aevi Genomic Medicine Inc

    • Heptares Therapeutics Ltd

    • Novartis AG

    • Johnson & Johnson

    • Sumitomo Dainippon Pharma Co Ltd

    • Toray Industries Inc

    • Richter Gedeon Nyrt

    • Addex Therapeutics Ltd

    • Eisai Co Ltd

    • Eli Lilly and Company

    • Merz Pharma GmbH & Co KgaA

    By Type:

    • Alloswitch-1

    • BMS-952048

    • BMS-955829

    • Dipraglurant ER

    • Others

    By End-User:

    • Major Depressive Disorder

    • Alcohol Assiction

    • Alzheimer's Disease

    • Others

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Metabotropic Glutamate Receptor 5 Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alloswitch-1 from 2014 to 2026

      • 1.3.2 Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of BMS-952048 from 2014 to 2026

      • 1.3.3 Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of BMS-955829 from 2014 to 2026

      • 1.3.4 Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Dipraglurant ER from 2014 to 2026

      • 1.3.5 Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Major Depressive Disorder from 2014 to 2026

      • 1.4.2 Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alcohol Assiction from 2014 to 2026

      • 1.4.3 Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alzheimer's Disease from 2014 to 2026

      • 1.4.4 Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Metabotropic Glutamate Receptor 5 Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Metabotropic Glutamate Receptor 5 by Major Types

      • 3.4.1 Market Size and Growth Rate of Alloswitch-1

      • 3.4.2 Market Size and Growth Rate of BMS-952048

      • 3.4.3 Market Size and Growth Rate of BMS-955829

      • 3.4.4 Market Size and Growth Rate of Dipraglurant ER

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Metabotropic Glutamate Receptor 5 Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Metabotropic Glutamate Receptor 5 by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Metabotropic Glutamate Receptor 5 in Major Depressive Disorder

      • 4.4.2 Market Size and Growth Rate of Metabotropic Glutamate Receptor 5 in Alcohol Assiction

      • 4.4.3 Market Size and Growth Rate of Metabotropic Glutamate Receptor 5 in Alzheimer's Disease

      • 4.4.4 Market Size and Growth Rate of Metabotropic Glutamate Receptor 5 in Others

    5 Market Analysis by Regions

    • 5.1 Japan Metabotropic Glutamate Receptor 5 Production Analysis by Regions

    • 5.2 Japan Metabotropic Glutamate Receptor 5 Consumption Analysis by Regions

    6 Hokkaido Metabotropic Glutamate Receptor 5 Landscape Analysis

    • 6.1 Hokkaido Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

    • 6.2 Hokkaido Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

    7 Tohoku Metabotropic Glutamate Receptor 5 Landscape Analysis

    • 7.1 Tohoku Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

    • 7.2 Tohoku Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

    8 Kanto Metabotropic Glutamate Receptor 5 Landscape Analysis

    • 8.1 Kanto Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

    • 8.2 Kanto Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

    9 Chubu Metabotropic Glutamate Receptor 5 Landscape Analysis

    • 9.1 Chubu Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

    • 9.2 Chubu Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

    10 Kinki Metabotropic Glutamate Receptor 5 Landscape Analysis

    • 10.1 Kinki Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

    • 10.2 Kinki Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

    11 Chugoku Metabotropic Glutamate Receptor 5 Landscape Analysis

    • 11.1 Chugoku Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

    • 11.2 Chugoku Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

    12 Shikoku Metabotropic Glutamate Receptor 5 Landscape Analysis

    • 12.1 Shikoku Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

    • 12.2 Shikoku Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

    13 Kyushu Metabotropic Glutamate Receptor 5 Landscape Analysis

    • 13.1 Kyushu Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

    • 13.2 Kyushu Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Bristol-Myers Squibb Company

      • 14.1.1 Bristol-Myers Squibb Company Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Aevi Genomic Medicine Inc

      • 14.2.1 Aevi Genomic Medicine Inc Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Heptares Therapeutics Ltd

      • 14.3.1 Heptares Therapeutics Ltd Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Novartis AG

      • 14.4.1 Novartis AG Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Johnson & Johnson

      • 14.5.1 Johnson & Johnson Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Sumitomo Dainippon Pharma Co Ltd

      • 14.6.1 Sumitomo Dainippon Pharma Co Ltd Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Toray Industries Inc

      • 14.7.1 Toray Industries Inc Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Richter Gedeon Nyrt

      • 14.8.1 Richter Gedeon Nyrt Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Addex Therapeutics Ltd

      • 14.9.1 Addex Therapeutics Ltd Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Eisai Co Ltd

      • 14.10.1 Eisai Co Ltd Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 Eli Lilly and Company

      • 14.11.1 Eli Lilly and Company Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 Merz Pharma GmbH & Co KgaA

      • 14.12.1 Merz Pharma GmbH & Co KgaA Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 94 Figures and 170 Tables)

    • Figure Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alloswitch-1 from 2014 to 2026

    • Figure Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of BMS-952048 from 2014 to 2026

    • Figure Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of BMS-955829 from 2014 to 2026

    • Figure Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Dipraglurant ER from 2014 to 2026

    • Figure Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Major Depressive Disorder from 2014 to 2026

    • Figure Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alcohol Assiction from 2014 to 2026

    • Figure Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alzheimer's Disease from 2014 to 2026

    • Figure Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Metabotropic Glutamate Receptor 5 Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Metabotropic Glutamate Receptor 5

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Metabotropic Glutamate Receptor 5 by Different Types from 2014 to 2026

    • Table Consumption Share of Metabotropic Glutamate Receptor 5 by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Alloswitch-1

    • Figure Market Size and Growth Rate of BMS-952048

    • Figure Market Size and Growth Rate of BMS-955829

    • Figure Market Size and Growth Rate of Dipraglurant ER

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Metabotropic Glutamate Receptor 5 by Different End-Users from 2014 to 2026

    • Table Consumption Share of Metabotropic Glutamate Receptor 5 by Different End-Users from 2014 to 2026

    • Figure Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Major Depressive Disorder from 2014 to 2026

    • Figure Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alcohol Assiction from 2014 to 2026

    • Figure Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alzheimer's Disease from 2014 to 2026

    • Figure Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Metabotropic Glutamate Receptor 5 Production by Regions

    • Table Japan Metabotropic Glutamate Receptor 5 Production Share by Regions

    • Figure Japan Metabotropic Glutamate Receptor 5 Production Share by Regions in 2014

    • Figure Japan Metabotropic Glutamate Receptor 5 Production Share by Regions in 2018

    • Figure Japan Metabotropic Glutamate Receptor 5 Production Share by Regions in 2026

    • Table Japan Metabotropic Glutamate Receptor 5 Consumption by Regions

    • Table Japan Metabotropic Glutamate Receptor 5 Consumption Share by Regions

    • Figure Japan Metabotropic Glutamate Receptor 5 Consumption Share by Regions in 2014

    • Figure Japan Metabotropic Glutamate Receptor 5 Consumption Share by Regions in 2018

    • Figure Japan Metabotropic Glutamate Receptor 5 Consumption Share by Regions in 2026

    • Table Hokkaido Metabotropic Glutamate Receptor 5 Consumption by Types from 2014 to 2026

    • Table Hokkaido Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2014

    • Figure Hokkaido Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2018

    • Figure Hokkaido Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2026

    • Table Hokkaido Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2014

    • Figure Hokkaido Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2018

    • Figure Hokkaido Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2026

    • Table Tohoku Metabotropic Glutamate Receptor 5 Consumption by Types from 2014 to 2026

    • Table Tohoku Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2014

    • Figure Tohoku Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2018

    • Figure Tohoku Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2026

    • Table Tohoku Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2014 to 2026

    • Table Tohoku Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2014

    • Figure Tohoku Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2018

    • Figure Tohoku Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2026

    • Table Kanto Metabotropic Glutamate Receptor 5 Consumption by Types from 2014 to 2026

    • Table Kanto Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2014 to 2026

    • Figure Kanto Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2014

    • Figure Kanto Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2018

    • Figure Kanto Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2026

    • Table Kanto Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2014 to 2026

    • Table Kanto Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2014

    • Figure Kanto Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2018

    • Figure Kanto Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2026

    • Table Chubu Metabotropic Glutamate Receptor 5 Consumption by Types from 2014 to 2026

    • Table Chubu Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2014 to 2026

    • Figure Chubu Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2014

    • Figure Chubu Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2018

    • Figure Chubu Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2026

    • Table Chubu Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2014 to 2026

    • Table Chubu Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2014

    • Figure Chubu Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2018

    • Figure Chubu Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2026

    • Table Kinki Metabotropic Glutamate Receptor 5 Consumption by Types from 2014 to 2026

    • Table Kinki Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2014 to 2026

    • Figure Kinki Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2014

    • Figure Kinki Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2018

    • Figure Kinki Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2026

    • Table Kinki Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2014 to 2026

    • Table Kinki Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2014

    • Figure Kinki Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2018

    • Figure Kinki Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2026

    • Table Chugoku Metabotropic Glutamate Receptor 5 Consumption by Types from 2014 to 2026

    • Table Chugoku Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2014

    • Figure Chugoku Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2018

    • Figure Chugoku Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2026

    • Table Chugoku Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2014 to 2026

    • Table Chugoku Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2014

    • Figure Chugoku Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2018

    • Figure Chugoku Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2026

    • Table Shikoku Metabotropic Glutamate Receptor 5 Consumption by Types from 2014 to 2026

    • Table Shikoku Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2014

    • Figure Shikoku Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2018

    • Figure Shikoku Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2026

    • Table Shikoku Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2014 to 2026

    • Table Shikoku Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2014

    • Figure Shikoku Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2018

    • Figure Shikoku Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2026

    • Table Kyushu Metabotropic Glutamate Receptor 5 Consumption by Types from 2014 to 2026

    • Table Kyushu Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2014

    • Figure Kyushu Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2018

    • Figure Kyushu Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2026

    • Table Kyushu Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2014 to 2026

    • Table Kyushu Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2014

    • Figure Kyushu Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2018

    • Figure Kyushu Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Bristol-Myers Squibb Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company

    • Table Product and Service Introduction of Bristol-Myers Squibb Company

    • Table Company Profile and Development Status of Aevi Genomic Medicine Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aevi Genomic Medicine Inc

    • Figure Sales and Growth Rate Analysis of Aevi Genomic Medicine Inc

    • Figure Revenue and Market Share Analysis of Aevi Genomic Medicine Inc

    • Table Product and Service Introduction of Aevi Genomic Medicine Inc

    • Table Company Profile and Development Status of Heptares Therapeutics Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Heptares Therapeutics Ltd

    • Figure Sales and Growth Rate Analysis of Heptares Therapeutics Ltd

    • Figure Revenue and Market Share Analysis of Heptares Therapeutics Ltd

    • Table Product and Service Introduction of Heptares Therapeutics Ltd

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Sumitomo Dainippon Pharma Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sumitomo Dainippon Pharma Co Ltd

    • Figure Sales and Growth Rate Analysis of Sumitomo Dainippon Pharma Co Ltd

    • Figure Revenue and Market Share Analysis of Sumitomo Dainippon Pharma Co Ltd

    • Table Product and Service Introduction of Sumitomo Dainippon Pharma Co Ltd

    • Table Company Profile and Development Status of Toray Industries Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Toray Industries Inc

    • Figure Sales and Growth Rate Analysis of Toray Industries Inc

    • Figure Revenue and Market Share Analysis of Toray Industries Inc

    • Table Product and Service Introduction of Toray Industries Inc

    • Table Company Profile and Development Status of Richter Gedeon Nyrt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Richter Gedeon Nyrt

    • Figure Sales and Growth Rate Analysis of Richter Gedeon Nyrt

    • Figure Revenue and Market Share Analysis of Richter Gedeon Nyrt

    • Table Product and Service Introduction of Richter Gedeon Nyrt

    • Table Company Profile and Development Status of Addex Therapeutics Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Addex Therapeutics Ltd

    • Figure Sales and Growth Rate Analysis of Addex Therapeutics Ltd

    • Figure Revenue and Market Share Analysis of Addex Therapeutics Ltd

    • Table Product and Service Introduction of Addex Therapeutics Ltd

    • Table Company Profile and Development Status of Eisai Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai Co Ltd

    • Figure Sales and Growth Rate Analysis of Eisai Co Ltd

    • Figure Revenue and Market Share Analysis of Eisai Co Ltd

    • Table Product and Service Introduction of Eisai Co Ltd

    • Table Company Profile and Development Status of Eli Lilly and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company

    • Figure Sales and Growth Rate Analysis of Eli Lilly and Company

    • Figure Revenue and Market Share Analysis of Eli Lilly and Company

    • Table Product and Service Introduction of Eli Lilly and Company

    • Table Company Profile and Development Status of Merz Pharma GmbH & Co KgaA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merz Pharma GmbH & Co KgaA

    • Figure Sales and Growth Rate Analysis of Merz Pharma GmbH & Co KgaA

    • Figure Revenue and Market Share Analysis of Merz Pharma GmbH & Co KgaA

    • Table Product and Service Introduction of Merz Pharma GmbH & Co KgaA

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.